Metabolic Solutions Development Company Highlights Plans for MSDC-0602 in NASH and Polycystic Kidney Disease

 KALAMAZOO, Mich., March 18, 2015 – Metabolic Solutions Development Company (MSDC), an emerging biopharmaceutical company developing first in class therapeutics to treat diseases associated with metabolic dysfunction, today announced that Stephen Benoit, CEO, will present a company overview at the 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference on Friday, March 20, 2015, at 2:30 p.m. ET at the Millennium Broadway Hotel in New York City.

Read more:  Metabolic Solutions Development Company Highlights Plans for MSDC-0602 in NASH and Polycystic Kidney Disease